This long-term retrospective cohort study included all chronic ambulatory dialysis patients between January 2014 and December 2016 in the main dialysis facilities under the umbrella of Hamad Medical Corporation (HMC) in the State of Qatar, including Fahd bin Jassim Kidney Center, which is the main and largest dialysis center in the State of Qatar, and three other satellite units (Al-Wakra, Al-Shahaniyah, and Al-Shamal units). The total number of dialysis patients in this cohort was 1080 (hemodialysis (HD) and peritoneal dialysis (PD) patients). The study protocol was approved by the Clinical Research Ethics Committee of HMC with IRB number 16319/16.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.